Search | IOVS | ARVO Journals

View

Showing 1 – 10 of 10

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Visual outcomes of central retinal artery occlusion treated with hyperbaric oxygen therapy

Luca Rosignoli; Edward Chu; John Carter; Daniel Johnson; Jeong-Hyeon Sohn; Sepehr Bahadorani

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2981 – F0222. doi:

ARVO Annual Meeting Abstract July 2019

Eplerenone and Spironolactone Have Similar Efficacy in the Treatment of Chronic Central Serous Chorioretinopathy

David Massop; Sepehr Bahadorani; Sejal Lahoti; Michael Singer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5008. doi:

ARVO Annual Meeting Abstract July 2018

Effects of topical brimonidine-timolol on injection intervals in patients receiving combination therapy for retinal vein occlusions

Chelsey Krambeer; Raul Membreno; Daniel Kermany; Sepehr Bahadorani; Kinley Beck; Kendall Wannamaker; Wayne Tie; Roberto Diaz-Rohena; Daniel Nolan; Jeong-Hyeon Sohn; Michael Singer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5443. doi:

ARVO Annual Meeting Abstract July 2018

A Survey of Retina Specialists’ Perspective on Symptomatic Vitreous Floaters (SVF) and its Management

Edward R Chu; Kinley Beck; Kendall Wannamaker; Daniel Kermany; Kyle MacLean; Raul Membreno; Sepehr Bahadorani; Calvin Mein; Arshad M. Khanani; Michael Singer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1833. doi:

ARVO Annual Meeting Abstract July 2018

The Effects of Temporary Intraocular Pressure Spikes after Intravitreal Dexamethasone Implantation (DEX) on the Retinal Nerve Fiber Layer

Kendall Wannamaker; Jordan Comstock; Sepehr Bahadorani; Nathan Gresores; Kyle Maclean; Edward R Chu; Kinley Beck; Chelsey Krambeer; Joshua Michael Iltis; Daniel Kermany; Roberto Diaz-Rohena; Daniel Nolan; Jeong-Hyeon Sohn; Michael Singer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2705. doi:

ARVO Annual Meeting Abstract July 2018

Reduction of sub-retinal fluid associated with central serous chorioretinopathy after the use of topical non-steroidal anti-inflammatory medications

Kyle MacLean; Sepehr Bahadorani; Nathan Gresores; Kendall Wannamaker; Michael Singer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3127. doi:

ARVO Annual Meeting Abstract June 2017

Repeated Ozurdex injections do not increase the frequency of ocular hypertension beyond 30 mmHg

Sepehr Bahadorani; Michael Jansen; Wayne Tie; Chelsey Krambeer; Daniel Kermany; Michael Singer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1068. doi:

ARVO Annual Meeting Abstract June 2017

Compliance Trends for Patients with Diabetic Macular Edema and Exudative Macular Degeneration in the United States vs. European Union

Chelsey Krambeer; Michael Jansen; Daniel Shafiee Kermany; Jana Waters; Wayne Tie; Sepehr Bahadorani; Michael Singer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):924. doi:

ARVO Annual Meeting Abstract June 2017

Reducing Dexamethasone intravitreal implant-related retinal injuries using a novel technique of intravitreal injection

Wayne Tie; Stan Conston; Ron Yamamoto; Michael Jansen; Sepehr Bahadorani; Chelsey Krambeer; Daniel Kermany; Michael Singer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4445. doi:

ARVO Annual Meeting Abstract June 2017

Systemic Antihypertensive Use Increases the Incidence of Glaucoma Progression

Daniel Shafiee Kermany; Chelsey Krambeer; Michael Jansen; Jana Waters; Sepehr Bahadorani; Wayne Tie; Michael Singer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):730. doi:

Advertisement